Position in LH
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$728,840
+$7,653 QoQ
Shares Held
2,603
-3.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#509
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026TRANSCEND CAPITAL ADVISORS, LLC holds $7,174,733 across 11 Diagnostics & Research names. LH ranks #3 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
12,094 | $2,303,665 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,977 | $991,188 | |
| 3 | LH |
Labcorp Holdings Inc.
This page
|
2,603 | $728,840 | |
| 4 | NTRA |
Natera, Inc.
|
2,405 | $652,837 | |
| 5 | ILMN |
Illumina, Inc.
|
3,604 | $633,691 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
886 | $469,216 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
2,241 | $433,006 | |
| 8 | WAT |
Waters Corp /De/
|
1,042 | $390,791 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $728,840 | 2,603 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $721,187 | 2,703 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $627,200 | 2,500 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $776,497 | 2,705 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $801,968 | 3,055 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $763,852 | 3,282 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $685,666 | 2,990 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $652,785 | 2,921 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $465,427 | 2,287 | Shares | Sole | 2024-07-02 | |
| No filing history on record for this holder in this stock. | ||||||